FDA approvals turn lab evidence

FDA approvals turn lab evidence, clinical studies, safety review, labeling and postmarket monitoring into decisions about drugs, vaccines or devices.

1. Frame 1FDA approvals turn a product claim into market permission through an agency gate for evidence, manufacturing, labeling, and safety risk review.
2. Frame 2IND packet inputs give FDA animal data, manufacturing details, protocols, prior human data, and investigator information before testing.
3. Frame 3Clinical phase sequence checks safety, dosage, effectiveness, side effects, and which patient groups the evidence covers.
4. Frame 4The review board and inspectors check scientific data, facilities, product quality, labeling, and benefit-risk thresholds.
5. Frame 5Failure mode: a clinical-hold stop gate blocks studies for unreasonable risk, weak investigators, misleading materials, or missing risk data.
6. Frame 6Postapproval monitoring chain watches label changes, postmarketing studies, safety-surveillance dashboards, and lot release.